Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 15,318.20 +138.38 0.91%
S&P 500 1,651.81 +12.77 0.78%
Nasdaq 3,482.18 +30.05 0.87%
Ticker Volume Price Price Delta
STOXX 50 2,700.93 -1.76 -0.07%
FTSE 100 6,374.21 +43.72 0.69%
DAX 8,229.51 +13.78 0.17%
Ticker Volume Price Price Delta
Nikkei 13,007.30 -25.84 -0.20%
Hang Seng 21,225.90 -0.02 0.00%
S&P/ASX 200 4,814.35 -11.53 -0.24%
  • Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Medical Equipment/Devices
  • Sub-Industry: Cardiovascular Devices

Thoratec Corp

+ Add to Watchlist

THOR:US

31.6700 USD 0.3900 1.22%

As of 17:20:00 ET on 06/18/2013.

Company Profile for Thoratec Corp (THOR)

Thoratec Corporation researches, develops, manufactures, and markets medical devices for circulatory support and vascular graft applications. The Company's products include a ventricular assist device, an implantable left ventricular heart assist device, a vascular access graft, and a coronary artery bypass graft. Thoratec also supplies whole-blood coagulation testing equipment.

Contact Information

Thoratec Corp

6035 Stoneridge Drive
Pleasanton, CA 94588
United States
Phone: 1-925-847-8600
Fax: 1-925-847-8574

Key Executives for Thoratec Corp (THOR)

Neil F DimickNon-Executive ChairmanGerhard F Burbach "Gary"President/CEO
David A LehmanSenior VP/Secy/Gen CnslTaylor C HarrisVP/CFO
Roxanne OulmanVP:Finance

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil